It is not classified as a controlled substance
Schulpis, K.H
May your doses stay consistent, your absorption stay optimal, and your results stay on track.
Regulates Appetite(LDN): Controls hunger and cravings, making it easier to maintain a calorie deficit
GLP-1s slow gastric emptying, the process of digestion in which food moves from the stomach into the rest of the digestive tract
Common side effects The most frequently reported side effects during the first four to eight weeks of semaglutide treatment include nausea (affecting 40-45% of users initially), constipation (approximately 24%), diarrhea (around 30%), abdominal bloating (roughly 20%), reduced appetite (this is actually the intended effect), fatigue (reported by 15-20% of users), and headaches (approximately 14%)